This page shows you your search results in order of relevance. This is page number 10.

Order by Relevance | Date

Total 5148657 results found since Jan 2013.

Smoking as a risk factor for multiple sclerosis
Conclusions: This study confirms that smoking is a risk factor for multiple sclerosis. It has the advantage of using analyses of cotinine levels in samples that were collected several years before disease onset, thus excluding any risk for recall bias and minimising the risk for reversed causation. Our results also suggest that the smoking related immunological events that contribute to the development of multiple sclerosis occur early in life.
Source: Multiple Sclerosis - July 1, 2013 Category: Neurology Authors: Salzer, J., Hallmans, G., Nystrom, M., Stenlund, H., Wadell, G., Sundstrom, P. Tags: Research Papers Source Type: research

Multiple Sclerosis Nurses
I try not to gush too much here in the pages of the Life With Multiple Sclerosis Blog.  Today, however, I am going to drop said restraint and let fly with great admiration for the Multiple Sclerosis Nurses in our lives. So often, I have found, it is my relationship with the staff at my neurologist’s office or at the MS centers I have attended that have been a major factor in my comfort in my choice of one doc or another.  If I were to continue that train of thought, I cannot say enough about the men and woman who have turned their nursing degrees and experience into the passionate specialty of working with people livin...
Source: Life with MS - June 17, 2013 Category: Other Conditions Authors: Trevis Gleason Tags: MS multiple sclerosis community Living with MS MS and family ms community MS doctors MS treatment Newly diagnosed Source Type: blogs

Contribution of cortical and white matter lesions to cognitive impairment in multiple sclerosis
Conclusions: These findings suggest a role of WM lesions in the development of cognitive deficits, especially information-processing speed, which may be higher than previously assumed. Abbreviations: CES-D: Center for Epidemiologic Studies Depression scale (ADS-L: Allgemeine Depressions Skala-L, German version of CES-D), CIS: clinically isolated syndrome, CL: cortical lesion, DIR: double inversion recovery, EDSS: Expanded Disability Status Scale, FSMC: fatigue scale for motor and cognitive functions, GM: grey matter, MRI: magnetic resonance imaging, MS: multiple sclerosis, PASAT-3: paced auditory serial addition test 3s, ...
Source: Multiple Sclerosis - August 30, 2013 Category: Neurology Authors: Papadopoulou, A., Muller-Lenke, N., Naegelin, Y., Kalt, G., Bendfeldt, K., Kuster, P., Stoecklin, M., Gass, A., Sprenger, T., Radue, E. W., Kappos, L., Penner, I.-K. Tags: Research Papers Source Type: research

First-line urological evaluation in multiple sclerosis: validation of a specific decision-making algorithm
Conclusion: The FLUE-MS algorithm was designed for neurologists and general practitioners, enabling identification of ‘red flags’, timely patient referral to specialist neuro-urology units, and appropriate first-line therapy.
Source: Multiple Sclerosis - November 25, 2013 Category: Neurology Authors: Amarenco, G., Chartier-Kastler, E., Denys, P., Jean, J. L., de Seze, M., Lubetzski, C. Tags: Research Papers Source Type: research

Rate of Agreement for Manual and Automated Techniques for Determination of New T2 Lesions in Children with Multiple Sclerosis and Acute Demyelination (P2.242)
CONCLUSIONS: Agreement is high between manual and automated methods for new T2 lesion determination. Overall, the automated method is more sensitive than the manual readers and identifies a higher number of lesions.Study Supported by: Canadian Multiple Sclerosis Scientific Research FoundationDisclosure: Dr. Verhey has received research support from the Canadian Institutes of Health, and the Multiple Sclerosis Society of Canada. Dr. Elliott has nothing to disclose. Dr. Branson has nothing to disclose. Dr. Philpott has nothing to disclose. Dr. Shroff has nothing to disclose. Dr. Arbel has nothing to disclose. Dr. Banwell has...
Source: Neurology - April 9, 2014 Category: Neurology Authors: Verhey, L., Elliott, C., Branson, H., Philpott, C., Shroff, M., Arbel, T., Banwell, B., Arnold, D. Tags: Pediatric Multiple Sclerosis and Other Demyelinating Diseases Source Type: research

Multiple Sclerosis and Stroke (P6.169)
Conclusion: There are consistent differences between the rates of ischemic stroke and TIA in patients with MS compared to those without MS, possibly indicating common inflammatory mechanisms.Disclosure: Dr. Sung has nothing to disclose. Dr. Amezcua has received personal compensation for activities with Biogen Idec, Questcor, Novartis and Acorda Therapeutics. Dr. Amezcua has received research support from Novartis and Acorda Therapeutics. Dr. Cen has nothing to disclose. Dr. Krug has nothing to disclose. Dr. Sanossian has received personal compensation for activities with Boehringer-Ingelheim Pharmaceutical Inc.
Source: Neurology - April 9, 2014 Category: Neurology Authors: Sung, E., Amezcua, L., Cen, S., Krug, A., Sanossian, N. Tags: Multiple Sclerosis Symptoms and Comorbidities Source Type: research

P025 A study of general health status and depression in multiple sclerosis patients and its relation with some of their individual characteristics in the Urmia City, Islamic Republic of Iran
Publication date: November 2014 Source:Multiple Sclerosis and Related Disorders, Volume 3, Issue 6 Author(s): N. Mohammadzaie , S. Taghavifar , A. Mosarrezaii , N. Ghasemzadeh , A.Y. Azar Introduction Mental health is a branch of general health that mostly discusses about decreasing psychological disorders in community. Somatic illness is known as a prominent risk factor affecting psychological health. Multiple sclerosis is classified in central nervous system disorders that destroys different segments of brain and spinal cord, by immune system attacks. Depression is associated with most of multiple sclerosis patients an...
Source: Multiple Sclerosis and Related Disorders - December 7, 2014 Category: Neurology Source Type: research

Bibliometric profile of the global scientific research on multiple sclerosis (2003-2012)
Conclusions: We emphasise the progressive growth of publications worldwide, the publication of articles in a wide variety of journals covering numerous subject areas, and the research leadership of Western countries, most notably European countries, the US and Canada.
Source: Multiple Sclerosis - February 13, 2015 Category: Neurology Authors: Aleixandre-Benavent, R., Alonso-Arroyo, A., Gonzalez de Dios, J., Vidal-Infer, A., Gonzalez-Munoz, M., Sempere, A. P. Tags: Research Papers Source Type: research

Multimodal Neurophysiological Evaluation of Primary Progressive Multiple Sclerosis - An Increasingly Valid Biomarker, with Limits
Conclusions Multi-modal evoked potential batteries generally show moderate and useful correlation with clinical status as measured by the regulatory standard of EDSS (r=.65 vs. mEPS p<0.005) and MSFC (r=.39 vs. mEPS p<0.05). The graded qualitative mEPS scoring system displayed the strongest relationship although the influence of scoring system applied appeared reassuringly minimal. Non-association with cognitive impairment is an important limitation however.
Source: Multiple Sclerosis and Related Disorders - August 8, 2015 Category: Neurology Source Type: research

Multimodal neurophysiological evaluation of primary progressive multiple sclerosis – An increasingly valid biomarker, with limits
Conclusions Multi-modal evoked potential batteries generally show moderate and useful correlation with clinical status as measured by the regulatory standard of EDSS (r=.65 vs. mEPS p<.005) and MSFC (r=.39 vs. mEPS p<.05). The graded qualitative mEPS scoring system displayed the strongest relationship although the influence of scoring system applied appeared reassuringly minimal. Non-association with cognitive impairment is an important limitation however.
Source: Multiple Sclerosis and Related Disorders - October 3, 2015 Category: Neurology Source Type: research

Multiple sclerosis associated genetic variants of CD226 impair regulatory T cell function
Recent association studies have linked numerous genetic variants with an increased risk for multiple sclerosis, although their functional relevance remains largely unknown. Here we investigated phenotypical and functional consequences of a genetic variant in the CD226 gene that, among other autoimmune diseases, predisposes to multiple sclerosis. Phenotypically, effector and regulatory CD4+ memory T cells of healthy individuals carrying the predisposing CD226 genetic variant showed, in comparison to carriers of the protective variant, reduced surface expression of CD226 and an impaired induction of CD226 after stimulation. ...
Source: Brain - October 26, 2015 Category: Neurology Authors: Piedavent-Salomon, M., Willing, A., Engler, J. B., Steinbach, K., Bauer, S., Eggert, B., Ufer, F., Kursawe, N., Wehrmann, S., Jäger, J., Reinhardt, S., Friese, M. A. Tags: Multiple Sclerosis/Neuroinflammation Original Articles Source Type: research

Quality of Life and Coping Strategies in Lebanese Multiple Sclerosis Patients: A Pilot Study
Publication date: Available online 17 December 2015 Source:Multiple Sclerosis and Related Disorders Author(s): Natali Farran, Diala Ammar, Hala Darwish Coping strategies used by Multiple Sclerosis patients play a key role in adjusting to the disease and affect their overall quality of life. This relationship has been investigated in developed countries, but none has been studied in developing ones such as Lebanon. Factors including barriers to health care delivery, economic pressure and political instability influence which coping strategies are used and often increases the use of negative coping mechanisms. The curre...
Source: Multiple Sclerosis and Related Disorders - December 18, 2015 Category: Neurology Source Type: research

Long-term efficacy and safety of intramuscular interferon beta-1a: Randomized postmarketing trial of two dosing regimens in japanese patients with relapsing remitting multiple sclerosis
Conclusions The results of this 2-year study demonstrate that IM IFN beta-1a can be used effectively and safely in Japanese patients with relapsing remitting multiple sclerosis for an extended period of time.
Source: Multiple Sclerosis and Related Disorders - February 3, 2016 Category: Neurology Source Type: research

Multi-parametric structural magnetic resonance imaging in relation to cognitive dysfunction in long-standing multiple sclerosis
Conclusion: From all imaging markers, deep grey matter atrophy and diffuse white matter damage emerged as the strongest predictors for cognitive dysfunction in long-standing multiple sclerosis.
Source: Multiple Sclerosis - March 23, 2016 Category: Neurology Authors: Daams, M., Steenwijk, M. D., Schoonheim, M. M., Wattjes, M. P., Balk, L. J., Tewarie, P. K., Killestein, J., Uitdehaag, B. M., Geurts, J. J., Barkhof, F. Tags: Original Research Papers Source Type: research

Physician compensation for industry-sponsored clinical trials in multiple sclerosis influences patient trust
Conclusions Results of this study demonstrate that physician payment for study participation in multiple sclerosis clinical trials is a potential conflict that can adversely affect patient trust.
Source: Multiple Sclerosis and Related Disorders - May 16, 2016 Category: Neurology Source Type: research